Expanding Advanced Lung Transplant Assessment and Utilization with Sarah Lowe XVIVO episode artwork

EPISODE · Aug 11, 2026 · 18 MIN

Expanding Advanced Lung Transplant Assessment and Utilization with Sarah Lowe XVIVO

from Empowered Patient Podcast · host Karen Jagoda

Sarah Lowe, Global Clinical Operations Director at XVIVO, develops technologies to preserve, assess, and transport organs for transplantation. With advanced assessment of donor lungs, the mission is to evaluate marginal organs better to address the critical challenge that only 2 out of 10 available lungs are currently accepted for transplant. With their first in-house ex vivo lung perfusion program, the goal is to increase organ utilization and expand access to transplants. Sarah explains, "At XVIVO, our vision really is that nobody should die waiting for a new organ. As a company, we develop technologies that allow our clinicians to preserve, assess, and transport organs. So, in doing so, we're able to be part of the solution by helping increase the number of organs available for transplantation. In my role at XVIVO, I get to work closely with clinical teams and partners to support the implementation of our technologies and their programs, not only in the US but around the world. So really everything that we do is centered around helping more patients receive those lifesaving transplants."   "So this collaboration is so incredibly important, not only for XVIVO. I think for the transplant community as a whole, it brings advanced lung assessment directly into the organ recovery process. XVIVO lung perfusion- you'll hear me say EVLP. It is placed into the workflow at the organ procurement organization level rather than in a separate step later in transplantation." "So Indiana Donor Network, I'll call it IDN, is the first organ recovery organization in the US that has an in-house lung perfusion program. And through this partnership, IDN can assess donor lungs using EVLP before transplantation decisions are finalized. So for us, it does matter for a few reasons. And I think it's important to emphasize that two in 10 lungs are transplanted, which means that 80% of them are declined." #XVIVO #OrganTransplantation #HealthcareInnovation #MedTech #PatientOutcomes #TransplantMedicine #LungTransplant #EVLP #OrganDonation #TransplantInnovation #IndianaDonorNetwork #PerfusionSolution #HealthcareInnovation #OPO #PatientCare XVIVOgroup.com Download the transcript here

Episode metadata supplied by the publisher feed · Published Aug 11, 2026

Embed this episode

NOW PLAYING

Expanding Advanced Lung Transplant Assessment and Utilization with Sarah Lowe XVIVO

0:00 18:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Empowered Patient Podcast?

This episode is 18 minutes long.

When was this Empowered Patient Podcast episode published?

This episode was published on August 11, 2026.

Can I download this Empowered Patient Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!